ARDX Q1 2026 Earnings EPS Misses Estimates by 142 Revenue Not Disclosed Ionis Pharmaceuticals Q1 2026 Earnings EPS Beat Driven by Cost Discipline Stock Holds Steady CMBM Q3 2024 Earnings EPS Surpasses Estimates but Revenue Details Omitted VSCO Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response M Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Intercorp Financial Services Inc IFS Q1 2026 Earnings EPS Surprise Lifts Results Despite Tepid Stock Reaction